Search results
Results From The WOW.Com Content Network
Lercanidipine (trade name Zanidip, among others) is an antihypertensive (blood pressure lowering) drug. It belongs to the dihydropyridine class of calcium channel blockers , which work by relaxing and opening the blood vessels allowing the blood to circulate more freely around the body.
The medical management of CCB toxicity may be difficult. [1] It may not improve with the usual treatments used for a low blood pressure and a slow heart rate. [ 9 ] Those who have no symptoms or signs six hours following taking an immediate release formulation and 24 hours after taking an extended release formulation generally need no further ...
A time management system is a designed combination of processes, tools, techniques and methods. ... to how long meetings last and instead focus on having high-quality ...
These effects are paradoxical to the use of benzodiazepines, both clinically and non-medically, in management of mental health conditions. [44] [45] Long-term benzodiazepine use may lead to the creation or exacerbation of physical and mental health conditions, which improve after six or more months of abstinence.
A fact from Lercanidipine appeared on Wikipedia's Main Page in the Did you know column on 11 August 2016 ... This page was last edited on 1 June 2024, ...
Renin–angiotensin–aldosterone system and potential steps of blockage. The renin–angiotensin–aldosterone system (RAAS) plays a key role in the pathology of cardiovascular disease, hypertension, diabetic kidney disease and heart failure. [17]
Verapamil, sold under various trade names, [1] is a calcium channel blocker medication used for the treatment of high blood pressure, angina (chest pain from not enough blood flow to the heart), and supraventricular tachycardia. [9]
Efonidipine is a dihydropyridine calcium channel blocker marketed by Shionogi & Co. of Japan.It was launched in 1995, under the brand name Landel (ランデル).The drug blocks both T-type and L-type calcium channels. [1]